Sodium‐glucose co‐transporter‐2 inhibitor use and <i>JAK2</i> unmutated erythrocytosis in 100 consecutive cases-Reference-Cited by-同舟云学术

Sodium‐glucose co‐transporter‐2 inhibitor use and JAK2 unmutated erythrocytosis in 100 consecutive cases

Published:2023-04-19 Issue:7 Volume:98 Page:
ISSN:0361-8609
Container-title:American Journal of Hematology
language:en
Short-container-title:American J Hematol

Author:

Gangat Naseema¹^ORCID,Abdallah Mostafa¹,Szuber Natasha²^ORCID,Saliba Antoine¹^ORCID,Alkhateeb Hassan¹,Al‐Kali Aref¹^ORCID,Begna Kebede H.¹^ORCID,Pardanani Animesh¹^ORCID,Tefferi Ayalew¹^ORCID

Affiliation:

1. Division of Hematology, Department of Internal Medicine Mayo Clinic Rochester Minnesota USA

2. Department of Hematology Université de Montréal Montréal Quebec Canada

Publisher

Wiley

Subject

Hematology

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1002/ajh.26933

Reference10 articles.

1. Gliflozins in the Management of Cardiovascular Disease

2. Empagliflozin, Cardiovascular Outcomes, and Mortality in Type 2 Diabetes

3. JAK2 wild-type erythrocytosis associated with sodium-glucose cotransporter 2 inhibitor therapy

4. Possible Mechanism of Hematocrit Elevation by Sodium Glucose Cotransporter 2 Inhibitors and Associated Beneficial Renal and Cardiovascular Effects

5. Effect of Empagliflozin on Erythropoietin Levels, Iron Stores, and Red Blood Cell Morphology in Patients With Type 2 Diabetes Mellitus and Coronary Artery Disease

Cited by 11 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Testosterone-induced erythrocytosis in transgender males: Challenges arising from an increasing prevalence of metabolic syndrome and wider therapeutic indications for prescribing SGLT2 inhibitor drugs;Best Practice & Research Clinical Endocrinology & Metabolism;2024-09

2. Revisiting the full blood count: Circulating blood cells and their role in coagulation;British Journal of Haematology;2024-08-07

3. Sodium–glucose cotransporter 2 inhibitors and the cancer patient: from diabetes to cardioprotection and beyond;Basic Research in Cardiology;2024-06-27

4. Myeloproliferative Neoplasms and Sodium-Glucose Co-Transporter-2 Inhibitors: A Case Series;Turkish Journal of Hematology;2024-05-30

5. Erythrocytosis and CKD: A Review;American Journal of Kidney Diseases;2024-04